Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Bavarian Nordic

234.60 DKK-0.26 %15.10, 13.34
Less than 1K followers

BAVA

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-0.26 %
+15.57 %
+28.97 %
+17.30 %
+22.92 %
+2.45 %
+69.88 %
-27.64 %
+64.48 %

Bavarian Nordic is a biochemistry company. Today, the company specializes in the development, manufacture, and distribution of vaccines against infectious diseases in connection with cancer treatment. In addition, vaccines against other serious diseases such as Ebola and cervical cancer are also being developed. The largest operations are located in Europe and in the U.S. Bavarian Nordic was founded in 1994 and is headquartered in Kvistgaard, Denmark.

Read more
Market cap
18.6B DKK
Turnover
20.13M DKK
Revenue
6.24B
EBIT %
28.89 %
P/E
13.33
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
13.11
2026

Interim report Q3'26

All
Research
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release12.10.2026, 17.53

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic
Regulatory press release12.10.2026, 17.53

Transaktioner i forbindelse med aktietilbagekøbsprogram for perioden 5. oktober 2026 til 9. oktober 2026

Bavarian Nordic
HCA Morgenbørs 08/10 - Fokus på renter i interview med cheføkonom Søren Kristensen fra AL Sydbank
Video08.10.2026, 09.55 by
Michael Friis, Nikolaj Pedersen

HCA Morgenbørs 08/10 - Fokus på renter i interview med cheføkonom Søren Kristensen fra AL Sydbank

Udsigt til en svag negativ åbning i Europa fra morgenstunden efter fald i Asien. Fokus på Bavarian Nordic (opjustering) og Zealand Pharma (fase 2-data i fedme). Gæst i studiet her til morgen er cheføkonom Søren Kristensen fra AL Sydbank, der bl.a. vil tale om rentestigningerne.

GreenMobilityALK-AbellóNNITZealand PharmaDemantBavarian NordicGubraNovo Nordisk

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release08.10.2026, 07.43

Bavarian Nordic opjusterer sine økonomiske forventninger til 2026 efter stærke resultater inden for Travel Health

Bavarian Nordic
Regulatory press release08.10.2026, 07.43

Bavarian Nordic Upgrades Full-Year 2026 Financial Guidance After Strong Travel Health Performance

Bavarian Nordic
Regulatory press release05.10.2026, 08.26

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic
Regulatory press release05.10.2026, 08.26

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic
Regulatory press release28.09.2026, 08.47

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic
Regulatory press release28.09.2026, 08.47

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic
Regulatory press release22.09.2026, 10.00

Bavarian Nordic – Notification of Holding of Treasury Shares

Bavarian Nordic
Regulatory press release22.09.2026, 10.00

Bavarian Nordic – meddelelse om besiddelse af egne aktier

Bavarian Nordic
Regulatory press release21.09.2026, 08.41

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic
Regulatory press release21.09.2026, 08.41

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic
Regulatory press release17.09.2026, 07.54

Tarja Stenvall Appointed Chief Executive Officer of Bavarian Nordic

Bavarian Nordic
Regulatory press release17.09.2026, 07.54

Bavarian Nordic udnævner Tarja Stenvall til administrerende direktør

Bavarian Nordic
Regulatory press release14.09.2026, 08.37

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic
Regulatory press release14.09.2026, 08.37

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic
Regulatory press release07.09.2026, 09.00

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic
Regulatory press release07.09.2026, 09.00

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic
Regulatory press release04.09.2026, 18.00

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Bavarian Nordic